Adverse events other than hypoglycaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment satisfaction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HbA1c (%)
1 finding from 1 review
Hypoglycaemic episodes a) Non‐serious hypoglycaemia
It is very uncertain whether drug dosage reduction changes hypoglycaemic episodes (a) Non‐serious hypoglycaemia compared with usual care (very low certainty).
1 finding from 1 review
Health‐related quality of life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events other than hypoglycaemia
1 finding from 1 review
All‐cause mortality
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment satisfaction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HbA1c (%)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment satisfaction
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
HbA1c (%)
1 finding from 1 review
Self‐care
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Hypoglycaemic episodes a) Non‐serious hypoglycaemia
It is very uncertain whether meglitinides changes hypoglycaemic episodes a) Non‐serious hypoglycaemia compared with sulphonylureas (very low certainty).
1 finding from 1 review
Health‐related quality of life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All‐cause mortality at end of intervention (range 2–10 months) · adult patients after liver transplantation.
It is very uncertain whether exercise changes all‐cause mortality at end of intervention (range 2–10 months) compared with control (very low certainty).
1 finding from 1 review
Serious adverse events (excluding deaths) at 26 weeks · adult patients after liver transplantation.
1 finding from 1 review
Non‐serious adverse events (range 2–10 months) · adult patients after liver transplantation.
1 finding from 1 review
Falls · older people living in the community (included trials conducting pre‐ and/or post‐hospital discharge home visits focusing on fall…
Home fall‐hazard reduction probably leads to lower rate of falls (falls per person‐years) compared with control (e.g. usual care) (moderate certainty).
1 finding from 1 review
Number of people who experienced one or more falls · older people living in the community (included trials conducting pre‐ and/or post‐hospital discharge home visits focusing on fall…
Home fall‐hazard reduction probably leads to lower number of people who experienced 1 or more falls compared with control (e.g. usual care) (moderate certainty).
1 finding from 1 review